Botanical species · safety record

Houttuynia cordata

The EFSA Compendium of Botanicals holds 6 constituent measurements and 1 adverse-effect record for Houttuynia cordata. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Houttuynia cordata (Thunb.)

6Constituent measurements
1Safety records
3Cited sources
102Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 102 licensed products naming Houttuynia cordata as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Aerial parts
  • Dried aerial part(s)
  • Herb
  • Herb top
  • Leaf
  • Whole plant
  • Whole plant(s)

What the records describe

Constituents measured

  • Aristolactam1
  • Cepharadione b1
  • Myrcene1
  • Norcepharadione b1
  • Piperolactam a1
  • Splendidine1

Plant parts

  • Aerial part of plants5
  • Leaves1
  • Unspecified1

Preparations

  • Solvent extraction6
  • Essential oil1

Effect types

  • Nephrotoxicity1

Target tissues

  • Urogenital: kidneys1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AristolactamAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Cepharadione bAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Norcepharadione bAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Piperolactam aAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SplendidineAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
MyrceneUnspecifiedEssential oil1.64 PercentGC-MSNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NephrotoxicityUrogenital: kidneysLeavesSolvent extractionRat (as animal)SubchronicResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yoshino, H., Imai, N., Nabae, K., Doi, Y., Tamano, S., Ogawa, K., Shirai, T. Thirteen-week oral toxicity study of Dokudami extract (Houttuynia cordata Thunb.) in F344/DuCrj rats. Journal of toxicologic pathology, 2006, vol. 18, no. 4, p. 175-182. DOI
  2. Ch, Muhammad Ishtiaq., Wen, Yang F., Cheng, YiYu. Gas chromatographic/mass spectrometric analysis of the essential oil of Houttuynia cordata Thunb by using on-column methylation with tetramethylammonium acetate . Journal of aoac international, 2007, vol. 90, no. 1, p. 60-67.
  3. Kim, SK., Ryu, SY., No, J., Choi, SU., Kim, YS. Cytotoxic alkaloids from Houttuynia cordata. ARCHIVES OF PHARMACAL RESEARCH, 2001, vol. 24, no. 6, p. 518-521. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue